Article Text
Statistics from Altmetric.com
The Orchard Sports Injury and Illness Classification System (OSIICS) was released in version 13 as an upgrade to the Orchard Sports Injury Classification System in early 2020,1 after being conceived at an IOC consensus meeting in Lausanne in October 2019,2 alongside a new version of the Sport Medicine Diagnostic Coding System (SMDCS). This was less than 3 years ago (a short time) but seemingly eons back in the prepandemic days when international flying was like catching a bus. As with all classification systems, the OSIICS requires reassessment and updating, in this case to OSIICS version 14.0 (figure 1).
Coding for COVID-19
Minor changes to OSIICS version 13 (versions 13.1–13.5) have been made over 2020 and 2021. Just prior to releasing version 13.1, an email was sent to other members of the IOC consensus team asking ‘Do you think this new viral illness, COVID-19, warrants a specific code?’ At that early stage, some respondents thought that for a sports diagnostic system it would be unjustified to start differentiating between virus types. As the impact of the pandemic became obvious, the need for differentiation was appreciated and the code MPIC was created for COVID-19 infection. The WHO has also created emergency codes related to COVID-19 for International Classification of Diseases (ICD)-10 and ICD-11.3
Already there have been additional codes related to the consensus statement on cycling injuries.4 Other expansions to OSIICS version 14 (online supplemental file 2) are additional sports cardiology diagnoses and female health conditions and further coding related to COVID-19 and even health conditions related to the vaccines (table 1).
Supplemental material
The need for specific sports injury coding systems (such as OSIICS and SMDCS) remains, as our ‘common’ sports injury diagnoses such as hamstring strain are not easily found in ICD codes.1 2 5 It has been important to add more illness codes as we continue to recognise the importance of tracking athlete illness as well as injury.6
Diagnoses and coding
In the sports and exercise medicine (SEM) specialty, it is also worth recognising that specific diagnosis is being questioned depending on the clinical scenario. For young elite athletes with (hopefully) little background degenerative change of the musculoskeletal system, specific diagnosis retains much of its traditional value. This is particularly for prognosis, as there is less background pathology to complicate diagnosis and in many cases imaging findings do correlate with recovery time. For the middle-aged or elderly patient, the huge value of promoting exercise and helping these patients access SEM services is becoming more apparent, but the value of specific diagnosis is less obvious in many cases. In fact, there is some evidence that the search for tissue-specific diagnoses can be harmful in terms of outcomes in musculoskeletal medicine.7 A meniscal tear of the knee or an acute lumbar disc prolapse is an important finding in a 21-year-old athlete, but we now legitimately question whether these diagnoses have any value whatsoever in those aged 60–70 years old, when the vast majority of the population will have evidence of these findings on asymptomatic screening imaging.8 It is therefore important that the OSIICS allows non-specific diagnostic codes and that practitioners use these with comfort when they are in situations where specific diagnoses are not warranted.
An Italian translation
OSIICS version 14 also comes with an Italian language version for the first time (curated by FG), which reflects its popularity in Europe in particular. Previous versions have been published in Spanish9 and Catalan10; any further language translations are welcome and will be added to free downloads, although it is possible to do a basic translation into most languages now with services such as Google Translate. OSIICS remains open-source and free to use with attribution.
Supplemental material
Ethics statements
Patient consent for publication
Acknowledgments
All contributors to previous versions of OSIICS and OSICS are acknowledged for their contributions.
Supplementary materials
Supplementary Data
This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.
Footnotes
Twitter @DrJohnOrchard
Contributors FG wrote the Italian translation and JO wrote the updates to version 14 and the majority of the text.
Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.
Competing interests None declared.
Provenance and peer review Not commissioned; externally peer reviewed.
Supplemental material This content has been supplied by the author(s). It has not been vetted by BMJ Publishing Group Limited (BMJ) and may not have been peer-reviewed. Any opinions or recommendations discussed are solely those of the author(s) and are not endorsed by BMJ. BMJ disclaims all liability and responsibility arising from any reliance placed on the content. Where the content includes any translated material, BMJ does not warrant the accuracy and reliability of the translations (including but not limited to local regulations, clinical guidelines, terminology, drug names and drug dosages), and is not responsible for any error and/or omissions arising from translation and adaptation or otherwise.